A. Grgic (Homburg, Germany), J. Coolen (Leuven, Belgium)
Late Breaking Abstract - Hyperpolarised gas MRI demonstrates sub-clinical progression in IPF over 6 months N. Weatherley (Sheffield, United Kingdom)
| |
Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality H. Robbie (London, United Kingdom)
| |
Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients H. Chan (Sheffield, United Kingdom)
| |
Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis L. Smith (Sheffield, United Kingdom)
| |
Ventilation heterogeneity reversibility: asthma, COPD or ACOS? R. Eddy (London, Canada)
| |
Parametric response map registered CT feature and small airway physiology analysis in asthma A. Bell (Leicester, United Kingdom)
| |
Clinical significance of 99mTc-technetril in indications of inflammatory processes in TB/HIV patients A. Perfilyev (Moscow, Russian Federation)
| |
Title:68 Gallium DOTA-NOC PET/CT as a predictor of disease activity in sarcoidosis A. Singh (New Delhi, India)
| |